Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
51 - 75 out of 509Page size: 25
  1. 2023
  2. Published

    Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)

    Rossing, Peter, Garweg, J. G., Anker, S. D., Osonoi, T., Pitt, B., Rosas, S. E., Ruilope, L. M., Zhu, D., Brinker, M., Finis, D., Leal, S., Schmelter, T. & Bakris, G., 2023, In: Diabetes, Obesity and Metabolism. 25, 3, p. 894-898 5 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  3. Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis

    Rossing, Peter, Bain, S. C., Bosch-Traberg, H., Sokareva, E., Heerspink, H. J. L., Rasmussen, S. & Mellbin, L. G., 2023, In: Cardiovascular Diabetology. 22, 11 p., 220.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial

    Chertow, G. M., Correa-Rotter, R., Vart, P., Jongs, N., McMurray, J. J. V., Rossing, Peter, Langkilde, A. M., Sjöström, C. D., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. & Dapa-Ckd Trial Committees Investigators, D. T. C. I., 2023, In: Journal of the American Heart Association. 12, 9, 22 p., e028739.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: The DECODE-CKD Trial

    Bartholdy, K. V., Johansen, N. D., Landler, N., Skaarup, K. G., Jensen, J., Bressendorff, I., Schou, Morten, Christensen, J., Feldt-Rasmussen, Bo, Vaduganathan, M., Solomon, S., Haynes, R., Persson, F., Rossing, Peter, Køber, Lars Valeur, Zannad, F., Hansen, Ditte & Biering-Sørensen, Tor, 2023, In: Kidney360. 4, 2, p. 143-149 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease: A Post Hoc Analysis of DAPA-CKD

    Schechter, M., Jongs, N., Chertow, G. M., Mosenzon, O., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Langkilde, A. M., Sjöström, C. D., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2023, In: Annals of Internal Medicine. 176, 1, p. 59-66 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials

    Sen, T., Curovic, V. R., Jongs, N., Laverman, G. D., Kooy, A., Persson, F., Rossing, Peter & Heerspink, H. J. L., 2023, In: Diabetes, Obesity and Metabolism. 25, 8, p. 2413-2418 6 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  8. Published

    Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial

    Laursen, J. C., Rotbain Curovic, V., Kroonen, M. Y. A. M., Jongs, N., Zobel, E. H., Hansen, T. W., Frimodt-Møller, M., Laverman, G. D., Kooy, A., Persson, F., Heerspink, H. J. L., Hansen, C. S. & Rossing, Peter, 2023, In: Diabetes, Obesity and Metabolism. 25, 10, p. 3064-3067 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  9. Published

    Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline

    the FIDELIO-DKD and FIGARO-DKD investigators, T. F. A. F. I., 2023, In: Diabetes, Obesity and Metabolism. 25, 6, p. 1512-1522 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trials

    Larsen, E. L., Andersen, A., Kjær, L. K., Eickhoff, M. K., Frimodt-Møller, M., Persson, F., Rossing, Peter, Lykkesfeldt, Jens, Knop, Filip Krag, Vilsbøll, Tina, Rungby, Jørgen & Poulsen, Henrik Enghusen, 2023, In: Free Radical Research. 57, 2, p. 140-151

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study

    Beernink, J. M., Persson, F., Jongs, N., Laverman, G. D., Chertow, G. M., McMurray, J. J. V., Langkilde, A. M., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2023, In: Diabetes Care. 46, 3, p. 602-607 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Endotrophin as a risk marker of mortality and kidney complications in a type 1 diabetes cohort

    Møller, A. L., Tougaard, N. H., Rasmussen, D. G. K., Genovese, F., Rønn, P. F., Hansen, T. W., Karsdal, M. A. & Rossing, Peter, 2023, In: Frontiers in Molecular Biosciences. 10, 1229579.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes

    Rossing, Peter, Groehl, F., Mernagh, P., Folkerts, K., Garreta-Rufas, A., Harris, J., Meredith, K., Carter, M., Åkerborg, Ö., Wanner, C. & Hobbs, F. D. R., 2023, In: Journal of Medical Economics. 26, 1, p. 935-943 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney disease

    Heinrich, N. S., Pedersen, R. P., Vestergaard, M. B., Lindberg, U., Andersen, U. B., Haddock, B., Hansen, T. W., Fornoni, A., Larsson, Henrik Bo Wiberg & Rossing, Peter, 2023, In: Diabetes, Obesity and Metabolism. 25, 9, p. 2605-2615 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis

    McEwan, P., Boyce, R., Sanchez, J. J. G., Sjöström, C. D., Stefansson, B., Nolan, S., Correa-Rotter, R., Rossing, Peter, Chertow, G. M., McMurray, J. J. V., Wheeler, D. C. & Heerspink, H. J. L., 2023, In: Nephrology Dialysis Transplantation. 38, 5, p. 1260-1270 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

    Filippatos, G., Anker, S. D., August, P., Coats, A. J. S., Januzzi, J. L., Mankovsky, B., Rossing, Peter, Ruilope, L. M., Pitt, B., Sarafidis, P., Teerlink, J. R., Kapelios, C. J., Gebel, M., Brinker, M., Joseph, A., Lage, A., Bakris, G. & Agarwal, R., 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 2, p. 183-191 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease

    Filippatos, G., Anker, S. D., Pitt, B., McGuire, D. K., Rossing, Peter, Ruilope, L. M., Butler, J., Jankowska, E. A., Michos, E. D., Farmakis, D., Farjat, A. E., Kolkhof, P., Scalise, A., Joseph, A., Bakris, G. L. & Agarwal, R., 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 1, p. 85-93 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

    Flack, J. M., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, Peter, Adler, S. G., Fried, L., Jamerson, K., Toto, R., Brinker, M., Farjat, A. E., Kolkhof, P., Lawatscheck, R., Joseph, A., Bakris, G. L. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2023, In: Kidney Medicine. 5, 12, 11 p., 100730.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

    Rosas, S. E., Ruilope, L. M., Anker, S. D., Pitt, B., Rossing, Peter, Bonfanti, A. A. C., Correa-Rotter, R., González, F., Munoz, C. F. J., Pergola, P., Umpierrez, G. E., Scalise, A., Scott, C., Lawatscheck, R., Joseph, A., Bakris, G. L. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2023, In: Kidney Medicine. 5, 10, 10 p., 100704.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use

    the FIDELIO-DKD and FIGARO-DKD investigators, T. F. A. F. I., 2023, In: Diabetes, Obesity and Metabolism. 25, 2, p. 407-416 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans

    Uglebjerg, N., Ahmadizar, F., Aly, D. M., Cañadas-Garre, M., Hill, C., Naber, A., Oddsson, A., Singh, S. S., Smyth, L., Trégouët, D. A., Chaker, L., Ghanbari, M., Steinthorsdottir, V., Ahlqvist, E., Hadjadj, S., Van Hoek, M., Kavousi, M., McKnight, A. J., Sijbrands, E. J., Stefansson, K. & 3 others, Simons, M., Rossing, Peter & Ahluwalia, T. S., 2023, In: Frontiers in Endocrinology. 14, 11 p., 1081741.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Gene expression signature predicts rate of type 1 diabetes progression

    Suomi, T., Starskaia, I., Kalim, U. U., Rasool, O., Jaakkola, M. K., Grönroos, T., Välikangas, T., Brorsson, C., Mazzoni, G., Bruggraber, S., Overbergh, L., Dunger, D., Peakman, M., Chmura, P., Brunak, S., Schulte, A. M., Mathieu, C., Knip, M., Lahesmaa, R., Elo, L. L. & 4 others, Pociot, Flemming, Johannesen, Jesper, Rossing, Peter & INNODIA consortium, I. C., 2023, In: EBioMedicine. 92, 18 p., 104625.

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Glucagon-like peptide-1 treatment reduces the risk of diabetes-type 2 related amputations: A cohort study in Denmark

    Schäfer, Z., Mathisen, A., Thomsen, T. R., Rossing, Peter & Kirketerp-Møller, K., 2023, In: Diabetes Research and Clinical Practice. 202, 7 p., 110799.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    HbA1c and beyond

    Rossing, Peter, 2023, In: Nephrology Dialysis Transplantation. 38, 1, p. 34-40 7 p.

    Research output: Contribution to journal › Review › Research › peer-review

  25. Published

    Hepatic Fibrosis Evaluated in Patients with Type 2 Diabetes with and without Chronic Kidney Disease

    Adrian, T., Hornum, Mads, Knop, Filip Krag, Christensen, Karl Bang, Almdal, Thomas Peter, Rossing, Peter, Lídaa, L. Í., Heinrich, N. S., Boer, V. O., Marsman, A., Petersen, E. T., Siebner, Hartwig Roman & Feldt-Rasmussen, Bo, 2023, In: Nephron. 147, 11, p. 673–684 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. Published

    Identification of biomarkers for glycaemic deterioration in type 2 diabetes

    Slieker, R. C., Donnelly, L. A., Akalestou, E., Lopez-Noriega, L., Melhem, R., Güneş, A., Abou Azar, F., Efanov, A., Georgiadou, E., Muniangi-Muhitu, H., Sheikh, M., Giordano, G. N., Åkerlund, M., Ahlqvist, E., Ali, A., Banasik, K., Brunak, S., Barovic, M., Bouland, G. A., Burdet, F. & 46 others, Canouil, M., Dragan, I., Elders, P. J. M., Fernandez, C., Festa, A., Fitipaldi, H., Froguel, P., Gudmundsdottir, V., Gudnason, V., Gerl, M. J., van der Heijden, A. A., Jennings, L. L., Hansen, M. K., Kim, M., Leclerc, I., Klose, C., Kuznetsov, D., Mansour Aly, D., Mehl, F., Marek, D., Melander, O., Niknejad, A., Ottosson, F., Pavo, I., Duffin, K., Syed, S. K., Shaw, J. L., Cabrera, O., Pullen, T. J., Simons, K., Solimena, M., Suvitaival, T., Wretlind, A., Rossing, Peter, Lyssenko, V., Legido Quigley, C., Groop, L., Thorens, B., Franks, P. W., Lim, G. E., Estall, J., Ibberson, M., Beulens, J. W. J., 't Hart, L. M., Pearson, E. R. & Rutter, G. A., 2023, In: Nature Communications. 14, 18 p., 2533.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...21 Next

ID: 12937790